Distributor inventory
Live attenuated Measles virus, Live attenuated Mumps virus, Live attenuated Rubella virus (MMR vaccine), 0.5 mL dose
Active immunization for prevention of measles, mumps and rubella (German measles) in eligible individuals as per immunization schedule
This live attenuated vaccine exposes the immune system to weakened measles, mumps and rubella viruses. It stimulates the body to produce protective antibodies and immune memory, helping prevent future infection or reduce disease severity.
For intramuscular or subcutaneous injection only; reconstitute the vial with the supplied diluent and administer 0.5 mL immediately after reconstitution as directed by a healthcare professional. Given according to national/doctor-recommended immunization schedule; do not self-administer.
Common side effects of TRESIVAC MMR VAC .5MLVIA may include:
Administer only under medical supervision. Contraindicated in severe allergy to any component (including neomycin/gelatin if present in formulation), severe immunodeficiency or immunosuppressive therapy, active untreated tuberculosis, and during pregnancy; avoid pregnancy for 1 month after vaccination. Postpone vaccination in moderate/severe acute illness with fever. Use caution in individuals with history of thrombocytopenia, seizures, or severe allergy. Rare risk of anaphylaxis; observe after vaccination as per protocol.
